Schedule 13G ownership disclosure

CHEMOMAB THERAPEUTICS LTD

Security class unavailable · CUSIP: 16385C104

Event date: 2021-03-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,631,260
Percent of class
10.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001068238-21-000088
Form type
SC 13G
Filer
Chemomab Therapeutics Ltd.
CIK
CIK 1534248
Filed
Mar 26, 2021
Reporting period
Mar 16, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub